[Molecular genetic predictors of the efficacy and safety of tamsulosin therapy]
- PMID: 36625625
[Molecular genetic predictors of the efficacy and safety of tamsulosin therapy]
Abstract
Individual differences in efficacy and safety of drugs between patients are a significant problem in modern pharmacotherapy. The bodys pharmacological response to the administration of a particular drug is determined by multiple factors, where up to 50% of the variability of the pharmacological response may be determined by the genetic variability of the body. The article presents an up-to-date review of the data on genetic polymorphisms influencing the efficacy and safety of tamsulosin therapy in patients with lower urinary tract symptoms associated with benign prostatic hyperplasia.
Keywords: BPH; CYP2D6; CYP3A4; LUTS; tamsulosin.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical